Latest News for: pdt

Edit

Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz� Red Light PDT to ...

Nasdaq Globe Newswire 08 Oct 2026
Submission seeks to extend the Ameluz� label beyond the face and scalp to treatment fields of up to approximately 240 cm� on the rest of the body, with an adjusted illumination protocol ... .
Edit

Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma (Form 8-K) (Biofrontera Inc)

Public Technologies 14 Sep 2026
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma ... This label expansion also furthers Biofrontera's strategy of broadening the clinical utility of its Red-Light PDT platform.
×